Potent, Simplified Derivatives of Immunosuppressive Agents

Case ID:
C04420
Disclosure Date:
3/16/2004
C04420: Potent, Simplified Derivatives of Immunosuppressive Agents
Technical Details:
Pateamine A (PatA), a metabolite from the marine sponge Mycale, is a potent inhibitor of the intracellular signal transduction pathway that emanates from the T-cell receptor and leads to the transcription of cytokines such as interleukin-2 (IL-2). Researchers at Johns Hopkins and Texas A&M have identified distinct binding and scaffolding domains in the PatA structure with respect to interactions with its putative cellular receptor(s). Based on these domains, a simplified PatA derivative (DMDAPatA) was generated that can be prepared in fewer synthetic steps relative to PatA and was found to exhibit greater potency in inhibition of IL-2 production relative to PatA. In addition, several other PatA derivatives were synthesized that displayed lower potency but marked stability relative to the natural product.
Looking for Partners:
These compounds may provide new pharmaceutical compounds for treating immune mediated disease and conditions.
Patent Information:
Title App Type Country Serial No. Patent No. File Date Issued Date Expire Date Patent Status
POTENT, SIMPLIFIED DERIVATIVES OF PATEAMINE A ORD: Ordinary Utility United States 10/388,257 7,230,021 3/13/2003 6/12/2007 2/9/2024 Granted
Inventors:
Category(s):
Get custom alerts for techs in these categories/from these inventors:
For Information, Contact:
Jeanine Pennington
jpennin5@jhmi.edu
410-614-0300
Save This Technology:
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum